Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An International, Randomized, Double-Blind, Placebo-Controlled Study of Valacyclovir for the Suppression of Recurrent Ano-Genital HSV Infections in HIV-Infected Subjects

NCT00005663 is registered in ClinicalTrials.gov with Glaxo Wellcome as lead sponsor.

NCT NCT00005663
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00005663 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An International, Randomized, Double-Blind, Placebo-Controlled Study of Valacyclovir for the Suppression of Recurrent Ano-Genital HSV Infections in HIV-Infected Subjects
Lead sponsor
Glaxo Wellcome
Phase
Phase 3
Overall status
Unknown status
Start date
June 30, 1999
Completion date
Not reported
Enrollment
Not reported
Sites
24

Conditions

As the registry lists them; a condition with its own page is linked.

herpes genitalis, herpes simplex, hiv infections